BRCA2 and breast cancer: More specifically, the rates of mutation in HR+/Her-2- BC are 1.7% for BRCA1 and 3.3% for BRCA2; whereas in TNBC, the mutation rate is 12.6% for BRCA1 and 1.1% for BRCA2 [11].